GO:0038123 toll-like receptor TLR1:TLR2 signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0038123 describes the biological process initiated when a ligand binds the heterodimeric TLR1:TLR2 receptor complex, leading to downstream transcriptional regulation.
• The TLR1:TLR2 heterodimer is the principal sensor for triacylated lipoproteins, and its activation depends on accessory proteins such as LBP and CD14.
• TLR1:TLR2 signaling drives mitochondrial reactive oxygen species production that augments macrophage bactericidal activity.
• Disturbances in TLR1:TLR2 pathway components are associated with increased susceptibility to infections in humans.
• Alterations in TLR1 and TLR2 expression have been reported in myelodysplastic syndrome, linking the pathway to hematologic disease.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of TLR1:TLR2 signaling in immune and non-immune cells.
Description
The toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123) is a biological process that begins when a ligand binds a heterodimeric complex of TLR1 and TLR2 and ends with regulation of downstream cellular responses such as transcription. This pathway is a central arm of innate immune recognition, specialized for detecting triacylated lipoproteins from bacteria and other microbes. Because TLR1:TLR2 signaling shapes inflammatory output, its dysregulation has been implicated in infectious disease susceptibility and in hematologic disorders such as myelodysplastic syndrome [2,6]. Researchers study GO:0038123 to understand how innate immune cells translate microbial cues into antimicrobial effector programs, including mitochondrial reactive oxygen species production that supports macrophage bactericidal activity. The pathway also intersects with accessory molecules such as lipopolysaccharide-binding protein (LBP) and CD14, which deliver ligands and enhance formation of the ternary signaling complex. In addition, TLR1:TLR2-like receptor pathways have been studied in non-immune contexts, including lung injury models where microbial metabolites modulate inflammation. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanism, key genes, disease links and experimental methods relevant to GO:0038123.
toll-like receptor TLR1:TLR2 signaling pathway At A Glance
| GO ID | GO:0038123 |
|---|---|
| GO term | toll-like receptor TLR1:TLR2 signaling pathway |
| Ontology | biological_process |
| Synonym | TLR2:TLR1 signaling pathway; toll-like receptor TLR1:TLR2 signalling pathway |
| Major function | Innate immune sensing of triacylated lipoproteins and initiation of downstream transcriptional responses |
| Key receptor | Heterodimeric TLR1:TLR2 complex |
| Accessory proteins | LBP and CD14 independently deliver ligands and enhance ternary complex formation |
| Downstream output | Mitochondrial ROS production and regulation of transcription |
| Disease relevance | Infectious disease susceptibility and myelodysplastic syndrome [2,6] |
What Is GO:0038123?
In plain terms, GO:0038123 describes the sequence of molecular events that occurs after a ligand binds to a TLR1:TLR2 heterodimer. The activated receptor transmits signals inside the cell, ultimately regulating downstream processes such as gene transcription. This definition is based on the QuickGO entry for GO:0038123, which specifies that the process is initiated by ligand binding to the heterodimeric TLR1:TLR2 complex and concludes with regulation of a downstream cellular process.
Why Is toll-like receptor TLR1:TLR2 signaling pathway Important in Cell Biology?
GO:0038123 is important because it defines the molecular logic by which the innate immune system detects a major class of bacterial lipoproteins and converts that recognition into inflammatory and antimicrobial programs. This pathway controls macrophage bactericidal activity through mitochondrial reactive oxygen species, making it a key determinant of host defense. Clinically, disturbances in TLR pathways are associated with increased susceptibility to infections in humans, and TLR alterations have been reported in myelodysplastic syndrome [2,6]. Understanding GO:0038123 therefore supports research into infection, inflammation, hematologic disease and host-microbe interactions.
• Defines innate immune recognition of triacylated lipoproteins by the TLR1:TLR2 heterodimer.
• Links ligand binding to downstream transcriptional regulation, a core feature of GO:0038123.
• Drives mitochondrial ROS-dependent macrophage bactericidal activity.
• Requires accessory proteins LBP and CD14 for efficient ligand delivery and ternary complex formation.
• Associated with increased susceptibility to infections when TLR pathways are disturbed.
• TLR1 and TLR2 alterations have been observed in myelodysplastic syndrome.
• Relevant to inflammatory conditions such as osteoarthritis and gastritis through CD14-related mechanisms.
• Modulated by microbial metabolites in lung injury models, indicating broader physiological roles.
• Provides a target for CRISPR-based functional dissection of innate immune signaling.
• Supports development of experimental models for infectious and inflammatory diseases.
What Happens During toll-like receptor TLR1:TLR2 signaling pathway?
Ligand recognition and ternary complex formation
In simple terms: First, the receptor grabs the bacterial ligand with help from accessory proteins.
The pathway begins when triacylated lipoproteins are delivered to the TLR1:TLR2 heterodimer. Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to TLR1 and TLR2 and enhance formation of the ternary signaling complex. This step ensures efficient ligand presentation and receptor activation, initiating the signaling cascade defined by GO:0038123.
Receptor activation and signal transmission
In simple terms: Once the ligand is bound, the receptor switches on and sends signals inside the cell.
After ligand binding, the activated TLR1:TLR2 heterodimer transmits signals to downstream adaptors and kinases. The QuickGO definition specifies that the signal is transmitted by the activated receptor and ends with regulation of a downstream cellular process, such as transcription. This transmission step is the central event of GO:0038123 and connects microbial detection to cellular responses.
Mitochondrial ROS production and bactericidal activity
In simple terms: The signal can also boost the cell's killing power by increasing reactive oxygen species.
TLR signaling augments macrophage bactericidal activity through mitochondrial reactive oxygen species. This demonstrates that GO:0038123 is not only a transcriptional pathway but also a functional driver of antimicrobial effector mechanisms. The production of mitochondrial ROS represents a key downstream output that enhances pathogen clearance.
Regulation of transcription and inflammatory output
In simple terms: Finally, the signal reaches the nucleus and changes which genes are turned on.
The pathway culminates in regulation of downstream cellular processes, including transcription. In bovine ovarian granulosa cells, curcumin alleviates HMGB1-mediated inflammation through the TLR2-NF-kB signaling pathway, illustrating how TLR2-dependent signaling can be modulated pharmacologically. This transcriptional output is a defining endpoint of GO:0038123.
Modulation by microbial and environmental factors
In simple terms: Outside factors, like gut bacteria or radiation, can tune this pathway up or down.
Low-dose radiation ameliorates PM2.5-induced lung injury through non-canonical TLR1/TLR2-like receptor pathways modulated by Akkermansia muciniphila. This indicates that GO:0038123-related signaling can be influenced by microbiota and environmental exposures, expanding its relevance beyond classical infection models.
Key Genes Involved in GO:0038123 toll-like receptor TLR1:TLR2 signaling pathway
The following genes and proteins are central to the toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123) and are frequently studied in functional and disease research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR1 | Forms heterodimer with TLR2 to recognize triacylated lipoproteins | Core receptor for GO:0038123; knockout and point-mutation studies |
| TLR2 | Forms heterodimer with TLR1; initiates signaling upon ligand binding | Central to pathway activation; target for CRISPR KO and overexpression |
| LBP | Delivers triacylated lipoproteins to TLR1 and TLR2 | Accessory protein enhancing ternary complex formation |
| CD14 | Independently delivers ligands and enhances ternary complex formation | Co-receptor for ligand presentation; relevant in osteoarthritis and gastritis |
| UNC93B1 | Essential for plasma membrane localization and signaling of TLR5 | Chaperone-like protein relevant to TLR trafficking |
| NF-kB components | Transcription factors downstream of TLR2 signaling | Readout of pathway activation in inflammation models |
| HMGB1 | Mediates inflammation through TLR2-NF-kB signaling | Ligand-associated mediator in inflammatory contexts |
| Akkermansia muciniphila | Microbial modulator of TLR1/TLR2-like pathways | Microbiota-based modulation in lung injury models |
| Mitochondrial ROS machinery | Produces ROS downstream of TLR signaling | Effector output for bactericidal activity |
| CSF1R | Associated with CD14 in osteoarthritis and gastritis | Potential crosstalk node in inflammatory disease |
| MyD88 (generic) | Adaptor in TLR signaling (generic pathway component) | Common downstream node in TLR signaling research |
| TIRAP (generic) | Adaptor in TLR2 signaling (generic pathway component) | Potential target for pathway-specific dissection |
| TRAF6 (generic) | E3 ligase in TLR signaling (generic pathway component) | Downstream signaling node for KO studies |
| IRAK4 (generic) | Kinase in TLR signaling (generic pathway component) | Candidate for point-mutation studies |
| NF-kB p65 (RELA) | Transcription factor regulating inflammatory genes | Readout for pathway activation |
| IL-6 (generic) | Cytokine induced by TLR signaling (generic downstream target) | Inflammatory biomarker in pathway studies |
| TNF-alpha (generic) | Cytokine induced by TLR signaling (generic downstream target) | Inflammatory biomarker in pathway studies |
| CXCL8 (generic) | Chemokine induced by TLR signaling (generic downstream target) | Neutrophil recruitment readout |
How Is toll-like receptor TLR1:TLR2 signaling pathway Regulated?
The TLR1:TLR2 signaling pathway is regulated at multiple levels. Accessory proteins LBP and CD14 independently deliver triacylated lipoproteins to TLR1 and TLR2 and enhance formation of the ternary signaling complex, thereby controlling the efficiency of pathway initiation. Downstream, the pathway converges on transcriptional regulators such as NF-kB, and pharmacological modulation with curcumin can alleviate HMGB1-mediated inflammation through the TLR2-NF-kB axis. Environmental and microbial factors also regulate the pathway; low-dose radiation ameliorates PM2.5-induced lung injury through non-canonical TLR1/TLR2-like receptor pathways modulated by Akkermansia muciniphila. In addition, UNC93B1 is essential for the plasma membrane localization and signaling of TLR5, highlighting the importance of trafficking chaperones in TLR pathway regulation. These layers of control ensure that GO:0038123 is tightly tuned to the cellular context.
toll-like receptor TLR1:TLR2 signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR1 | Infectious disease susceptibility | TLR1 knockout macrophages and infection challenge |
| TLR2 | Myelodysplastic syndrome | TLR2 knockout hematopoietic cells and inflammatory assays |
| CD14 | Osteoarthritis and gastritis | CD14 knockout chondrocytes and gastric epithelial cells |
| HMGB1 | Inflammation via TLR2-NF-kB | HMGB1 overexpression in granulosa cells |
| Akkermansia muciniphila | Lung injury modulation | Microbiota-treated lung injury models |
Infectious disease susceptibility
Disturbances in Toll-like receptor pathways are associated with increased susceptibility to infections in humans. Because GO:0038123 is a major innate immune sensing route for bacterial lipoproteins, defects in TLR1:TLR2 signaling can impair pathogen recognition and host defense [3,6]. This makes the pathway a focus for studies of bacterial infection and immune deficiency.
Myelodysplastic syndrome
Toll-like receptor alterations have been reported in myelodysplastic syndrome, linking TLR pathway dysregulation to hematologic disease. Although the precise mechanisms remain under investigation, these findings suggest that GO:0038123-related signaling may contribute to the inflammatory bone marrow environment in MDS.
Inflammatory and metabolic conditions
The role of CD14 and CSF1R has been explored in osteoarthritis and gastritis, indicating that TLR1:TLR2-associated co-receptors participate in inflammatory disease processes beyond classical infection. Curcumin alleviates HMGB1-mediated inflammation through the TLR2-NF-kB signaling pathway in bovine ovarian granulosa cells, further supporting the pathway's role in inflammation.
Lung injury and environmental exposure
Low-dose radiation ameliorates PM2.5-induced lung injury through non-canonical TLR1/TLR2-like receptor pathways modulated by Akkermansia muciniphila. This suggests that GO:0038123-related signaling can be modulated by microbiota and environmental stressors, with potential therapeutic implications for inflammatory lung disease.
From toll-like receptor TLR1:TLR2 signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TLR1 required for lipoprotein sensing? | TLR1 knockout cell line |
| Does a point mutation in TLR2 alter signaling? | TLR2 point-mutation knock-in |
| How does tagged TLR1 localize in cells? | Tagged TLR1 knock-in |
| Does overexpression of CD14 enhance pathway activation? | CD14 overexpression cell model |
| Which genes are downstream of TLR1:TLR2 activation? | CRISPR library screening with pathway readout |
| What is the transcriptional signature of pathway activation? | RNA-seq in wild-type vs knockout cells |
How to Study the toll-like receptor TLR1:TLR2 signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes downstream of TLR1:TLR2 | Pathway activation profiling |
| Proteomics | Protein abundance and interactions | Identification of signaling complexes |
| Phosphoproteomics | Kinase activity and signaling nodes | Mapping downstream cascades |
| Live-cell imaging | Receptor localization and ROS production | Functional readout of bactericidal activity |
| CRISPR library screening | Gene essentiality and modifiers | Discovery of novel pathway regulators |
| Bioinformatics | Pathway enrichment and network analysis | Integration of multi-omics datasets |
| Flow cytometry | Surface TLR1:TLR2 expression | Immune cell phenotyping |
| ELISA | Cytokine output such as IL-6 and TNF-alpha | Inflammatory response quantification |
Transcriptional profiling by RNA-seq
RNA-seq can measure the transcriptional output of GO:0038123 after ligand stimulation or genetic perturbation. Because the pathway ends with regulation of transcription, RNA-seq is a direct way to quantify downstream gene expression changes in wild-type versus knockout cells.
Proteomics and phosphoproteomics
Proteomic approaches can identify signaling intermediates and post-translational modifications downstream of TLR1:TLR2 activation. Given that the pathway involves receptor-proximal signaling and transcriptional regulation, phosphoproteomics can reveal kinase cascades activated by the heterodimer.
Imaging of receptor localization and ROS
Imaging can track TLR1:TLR2 localization and mitochondrial ROS production. TLR signaling augments macrophage bactericidal activity through mitochondrial ROS, so live-cell imaging of ROS reporters is a functional readout of pathway activity.
CRISPR screening and bioinformatics
CRISPR library screening combined with bioinformatics can identify genes that modify GO:0038123 signaling. This approach is useful for uncovering novel regulators of the pathway and for validating candidate genes from transcriptomic or proteomic datasets.
How CRISPR Can Be Used to Study GO:0038123 toll-like receptor TLR1:TLR2 signaling pathway
Knockout
CRISPR knockout of TLR1, TLR2 or accessory genes such as CD14 can abolish GO:0038123 signaling and reveal its contribution to downstream responses. Knockout models are essential for establishing causality between pathway components and phenotypes such as cytokine production or bactericidal activity.
Point Mutation
Point-mutation knock-in can model disease-associated variants or disrupt specific residues in TLR1 or TLR2. This approach helps determine whether a single amino acid change alters ligand recognition or signal transmission in GO:0038123.
Knock-in
Tagged knock-in of TLR1 or TLR2 enables visualization and biochemical isolation of the receptor complex. Because the pathway depends on heterodimer formation and ternary complex assembly, tagged knock-in models are valuable for studying receptor trafficking and interactions.
Overexpression
Overexpression of TLR1, TLR2, CD14 or LBP can enhance pathway activation and amplify downstream transcriptional responses. Overexpression models are useful for studying gain-of-function effects and for screening modulators of GO:0038123.
How EDITGENE Supports toll-like receptor TLR1:TLR2 signaling pathway Research
Researchers studying toll-like receptor TLR1:TLR2 signaling pathway-related genes often need to determine whether a candidate gene is causally involved in ligand sensing, signal transmission or downstream transcriptional regulation. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations for such studies.
Contact EDITGENE today to design your custom CRISPR model for toll-like receptor TLR1:TLR2 signaling pathway research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TIRAP Knockout HEK293 Cell Line | EDJ-KQ594 | Human | 114609 | Details Get a Quote |
| SCIMP Knockout HEK293 Cell Line | EDJ-KQ15188 | Human | 388325 | Details Get a Quote |
| TLR1 Knockout HEK293 Cell Line | EDJ-KQ15744 | Human | 7096 | Details Get a Quote |
| TLR2 Knockout HEK293 Cell Line | EDJ-KQ17909 | Human | 7097 | Details Get a Quote |
| TLR2 Knockout A-549 Cell Line | EDC90495 | Human | 7097 | Details Get a Quote |
| TIRAP Knockout A-549 Cell Line | EDJ-KQ19032 | Human | 114609 | Details Get a Quote |
| TIRAP Knockout HCT 116 Cell Line | EDJ-KQ19033 | Human | 114609 | Details Get a Quote |
| TIRAP Knockout HeLa Cell Line | EDJ-KQ19034 | Human | 114609 | Details Get a Quote |
| TLR1 Knockout HCT 116 Cell Line | EDJ-KQ45440 | Human | 7096 | Details Get a Quote |
| TLR1 Knockout A-549 Cell Line | EDJ-KQ46667 | Human | 7096 | Details Get a Quote |
| TLR2 Knockout THP-1 Cell Line | EDJ-KZ51 | Human | 7097 | Details Get a Quote |
| TLR1 Knockout THP-1 Cell Line | EDJ-KZ509 | Human | 7096 | Details Get a Quote |
| TLR1 Knockout HeLa Cell Line | EDJ-KQ54665 | Human | 7096 | Details Get a Quote |
| TLR2 Knockout HeLa Cell Line | EDJ-KQ54666 | Human | 7097 | Details Get a Quote |
| SCIMP Knockout HeLa Cell Line | EDJ-KQ60015 | Human | 388325 | Details Get a Quote |
Displaying Records 1 To 15 Of 19 Records
Frequently Asked Questions About toll-like receptor TLR1:TLR2 signaling pathway
What is GO:0038123?
GO:0038123 is the Gene Ontology term for the toll-like receptor TLR1:TLR2 signaling pathway, a biological process initiated by ligand binding to the TLR1:TLR2 heterodimer and ending with regulation of a downstream cellular process such as transcription.
What genes are involved in toll-like receptor TLR1:TLR2 signaling pathway?
Key genes include TLR1, TLR2, LBP, CD14 and downstream inflammatory mediators such as NF-kB components [3,4].
What ligands activate TLR1:TLR2 signaling?
Triacylated lipoproteins are delivered to TLR1 and TLR2 by LBP and CD14, which enhance formation of the ternary signaling complex.
How does TLR1:TLR2 signaling affect macrophages?
TLR signaling augments macrophage bactericidal activity through mitochondrial reactive oxygen species.
Is TLR1:TLR2 signaling involved in disease?
Yes, disturbances in TLR pathways are associated with increased susceptibility to infections, and TLR alterations have been reported in myelodysplastic syndrome [2,6].
What is the role of CD14 in this pathway?
CD14 independently delivers triacylated lipoproteins to TLR1 and TLR2 and enhances formation of the ternary signaling complex.
Can curcumin modulate TLR2 signaling?
Curcumin alleviates HMGB1-mediated inflammation through the TLR2-NF-kB signaling pathway in bovine ovarian granulosa cells.
How is TLR1:TLR2 signaling studied in the lab?
Common methods include RNA-seq, proteomics, live-cell imaging of ROS, and CRISPR knockout or overexpression models [1,3].
What diseases are linked to TLR1 and TLR2 alterations?
Myelodysplastic syndrome and increased infection susceptibility have been linked to TLR pathway disturbances [2,6].
Does the microbiome influence TLR1:TLR2 signaling?
Yes, Akkermansia muciniphila modulates non-canonical TLR1/TLR2-like receptor pathways in lung injury models.
Conclusion
GO:0038123 provides a precise framework for studying how the TLR1:TLR2 heterodimer detects triacylated lipoproteins and converts that recognition into transcriptional and antimicrobial responses. The pathway is central to innate immunity, with documented roles in macrophage bactericidal activity, infection susceptibility and hematologic disease [1,2,6]. CRISPR-based models, combined with transcriptomics, proteomics and imaging, offer powerful tools to dissect the mechanism and regulation of this pathway. Continued research on GO:0038123 will advance our understanding of host defense and inflammatory disease.
References
- 1. West AP et al.. 2011. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS.. Nature 472(7344):476-80 PMID: 21525932
- 2. Wei Y et al.. 2013. Toll-like receptor alterations in myelodysplastic syndrome.. Leukemia 27(9):1832-40 PMID: 23765228
- 3. Ranoa DRE et al.. 2013. Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex.. J Biol Chem 288(14):9729-9741 PMID: 23430250
- 4. Liu S et al.. 2025. Curcumin Alleviates HMGB1-Mediated Inflammation Through the Signaling Pathway of TLR2-NF-κB in Bovine Ovarian Granulosa Cells.. Int J Mol Sci 26(18) PMID: 41009742
- 5. Wang L et al.. 2025. Low-dose radiation ameliorates PM2.5-induced lung injury through non-canonical TLR1/TLR2-like receptor pathways modulated by Akkermansia muciniphila.. Ecotoxicol Environ Saf 289:117625 PMID: 39752914
- 6. Frazão JB et al.. 2013. Toll-like receptors' pathway disturbances are associated with increased susceptibility to infections in humans.. Arch Immunol Ther Exp (Warsz) 61(6):427-43 PMID: 24057516
- 7. Zheng M et al.. 2023. The role of CD14 and CSF1R in osteoarthritis and gastritis.. Medicine (Baltimore) 102(43):e35567 PMID: 37904379
- 8. Huh JW et al.. 2014. UNC93B1 is essential for the plasma membrane localization and signaling of Toll-like receptor 5.. Proc Natl Acad Sci U S A 111(19):7072-7 PMID: 24778236
